Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The daily Top 10 COVID papers

Breast Cancer

Free Subscription 25.01.2021 1 Am J Clin Oncol 2 Am J Epidemiol 1 Am J Surg 1 Ann Surg 2 Ann Surg Oncol 6 BMC Cancer 1 Br J Cancer 6 Breast Cancer 1 Breast Cancer (Dove Med Press) 2 Breast Cancer Res 16 Breast Cancer Res Treat 10 Breast J 3 Cancer 2 Cancer Epidemiol Biomarkers Prev 1 Cancer Lett 1 Cancer Res 1 Carcinogenesis 2 Clin Breast Cancer 1 Clin Cancer Res 2 Eur Radiol 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 2 J Biol Chem 1 J Natl Cancer Inst 2 Lancet Oncol 1 Mod Pathol 3 N Engl J Med 2 NPJ Breast Cancer 3 Oncogene 1 PLoS Comput Biol 5 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. VALERIO MR, Arrivas Bajardi E, Arcara CC, Borsellino N, et al
   Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety.
   Am J Clin Oncol. 2021 Jan 20. pii: 00000421-900000000-98598.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

2. BRAILLON A
   Modelling breast cancer screening after a decade of most controversial reports: missing the forest for the trees?
   Am J Epidemiol. 2021 Jan 18. pii: 6101771. doi: 10.1093.
   PubMed        
   
   
3. SEIGNEURIN A, Exbrayat C, Molinie F, Croisier L, et al
   The authors reply to: Modelling breast cancer screening after a decade of most controversial reports: missing the forest for the trees?
   Am J Epidemiol. 2021 Jan 18. pii: 6101772. doi: 10.1093.
   PubMed        
   
   

   
   Am J Surg

4. HUYNH V, Tevis S
   Surgical management of invasive lobular carcinoma: Is less more?
   Am J Surg. 2021;221:30-31.
   PubMed        
   
   

   
   Ann Surg

5. NEWMAN LA
   Cascading Consequences of Systemic Racism on Public Health.
   Ann Surg. 2021;273:10-12.
   PubMed        
   
   

   
   Ann Surg Oncol

6. SMITH BD, Kuerer HM
   Same-Day Breast Cancer Surgery and TARGIT-IORT: Better than Selective Omission of Radiotherapy?
   Ann Surg Oncol. 2021 Jan 15. pii: 10.1245/s10434-021-09588.
   PubMed        
   
   
7. WU ZY, Ko B
   ASO Author Reflections: Risk of Locoregional Recurrence After Nipple-Sparing Mastectomy and Immediate Breast Reconstruction for Pure Ductal Carcinoma In Situ.
   Ann Surg Oncol. 2020;27:1636-1637.
   PubMed        
   
   

   
   BMC Cancer

8. NYHOF BB, Wright FC, Look Hong NJ, Groot G, et al
   Identifying opportunities to support patient-centred care for ductal carcinoma in situ: qualitative interviews with clinicians.
   BMC Cancer. 2020;20:364.
   PubMed         Abstract available
   
   
9. WHITEHEAD I, Irwin GW, Bannon F, Coles CE, et al
   The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making.
   BMC Cancer. 2021;21:90.
   PubMed         Abstract available
   
   
10. PARK JH, Lee DH, Kim SI, Kim NK, et al
    Moderate to vigorous physical activity participation associated with better quality of life among breast and colorectal cancer survivors in Korea.
    BMC Cancer. 2020;20:365.
    PubMed         Abstract available
    
    
11. EVANGELISTA AF, Oliveira RJ, O Silva VA, D C Vieira RA, et al
    Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    BMC Cancer. 2021;21:76.
    PubMed         Abstract available
    
    
12. HUO X, Li J, Zhao F, Ren D, et al
    The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:78.
    PubMed         Abstract available
    
    
13. JUNG SM, Jeon BJ, Woo J, Ryu JM, et al
    Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander?
    BMC Cancer. 2021;21:88.
    PubMed         Abstract available
    
    

    
    Br J Cancer

14. CABEL L, Berger F, Cottu P, Loirat D, et al
    Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial.
    Br J Cancer. 2021 Jan 21. pii: 10.1038/s41416-020-01227.
    PubMed         Abstract available
    
    

    
    Breast Cancer

15. TANAKA Y, Ohno T, Kadonaga T, Kidokoro Y, et al
    Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 - negative subtype.
    Breast Cancer. 2021 Jan 22. pii: 10.1007/s12282-021-01217.
    PubMed         Abstract available
    
    
16. OHNUKI K, Tohno E, Tsunoda H, Uematsu T, et al
    Correction to: Overall assessment system of combined mammography and ultrasound for breast cancer screening in Japan.
    Breast Cancer. 2021 Jan 21. pii: 10.1007/s12282-021-01216.
    PubMed        
    
    
17. LIU X, Chang Q, Wang H, Qian H, et al
    Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer.
    Breast Cancer. 2021 Jan 21. pii: 10.1007/s12282-021-01215.
    PubMed         Abstract available
    
    
18. SONG BI
    A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer.
    Breast Cancer. 2021 Jan 17. pii: 10.1007/s12282-020-01202.
    PubMed         Abstract available
    
    
19. CHEN Y, Noma S, Taguchi Y, Takahashi M, et al
    Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan.
    Breast Cancer. 2021 Jan 16. pii: 10.1007/s12282-020-01207.
    PubMed         Abstract available
    
    
20. HSUEH EJ, Loh EW, Lin JJ, Tam KW, et al
    Effects of yoga on improving quality of life in patients with breast cancer: a meta-analysis of randomized controlled trials.
    Breast Cancer. 2021 Jan 15. pii: 10.1007/s12282-020-01209.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

21. DA SILVA JL, Rodrigues FR, de Mesquita GG, Fernandes PV, et al
    Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment.
    Breast Cancer (Dove Med Press). 2021;13:31-44.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

22. ALHENC-GELAS M, Cabel L, Berger F, Delaloge S, et al
    Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study.
    Breast Cancer Res. 2021;23:9.
    PubMed         Abstract available
    
    
23. SCHMID P, Sablin MP, Bergh J, Im SA, et al
    A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer.
    Breast Cancer Res. 2021;23:8.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

24. NAKASHOJI A, Hayashida T, Yamaguchi S, Kawai Y, et al
    Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development.
    Breast Cancer Res Treat. 2021 Jan 18. pii: 10.1007/s10549-020-06087.
    PubMed         Abstract available
    
    
25. JIA M, Lin X, Zhou X, Yan H, et al
    Diagnostic performance of automated breast ultrasound and handheld ultrasound in women with dense breasts.
    Breast Cancer Res Treat. 2020;181:589-597.
    PubMed         Abstract available
    
    
26. JAFARI L, Akhter N
    Heart failure prevention and monitoring strategies in HER2-positive breast cancer: a narrative review.
    Breast Cancer Res Treat. 2021 Jan 22. pii: 10.1007/s10549-021-06096.
    PubMed         Abstract available
    
    
27. KARADSHEH MJ, Tyrell R, Deng M, Egleston BL, et al
    Early postoperative outcomes in implant, pedicled, and free flap reconstruction for breast cancer: an analysis of 23,834 patients from the ACS-NSQIP datasets.
    Breast Cancer Res Treat. 2021 Jan 19. pii: 10.1007/s10549-020-06073.
    PubMed         Abstract available
    
    
28. SHECKTER CC, Aliu O, Bailey C, Liu J, et al
    Exploring provider- and practice-level drivers of cost-consciousness in breast cancer reconstruction-secondary analysis of a survey of the American Society of Plastic Surgeons.
    Breast Cancer Res Treat. 2021 Jan 19. pii: 10.1007/s10549-020-06085.
    PubMed         Abstract available
    
    
29. MONDACA JM, Guijarro ACC, Flamini MI, Sanchez AM, et al
    Heregulin-induced cell migration is prevented by trastuzumab and trastuzumab-emtansine in HER2+ breast cancer.
    Breast Cancer Res Treat. 2021 Jan 20. pii: 10.1007/s10549-020-06089.
    PubMed         Abstract available
    
    
30. IWASE T, Wang X, Shrimanker TV, Kolonin MG, et al
    Body composition and breast cancer risk and treatment: mechanisms and impact.
    Breast Cancer Res Treat. 2021 Jan 21. pii: 10.1007/s10549-020-06092.
    PubMed         Abstract available
    
    
31. SUEOKA S, Sasada S, Masumoto N, Emi A, et al
    Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer.
    Breast Cancer Res Treat. 2021 Jan 23. pii: 10.1007/s10549-020-06088.
    PubMed         Abstract available
    
    
32. OBA T, Ono M, Matoba H, Uehara T, et al
    HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells.
    Breast Cancer Res Treat. 2021 Jan 16. pii: 10.1007/s10549-020-06033.
    PubMed         Abstract available
    
    
33. OBDEIJN IM, Mann RM, Loo CCE, Lobbes M, et al
    The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers.
    Breast Cancer Res Treat. 2020;181:581-588.
    PubMed         Abstract available
    
    
34. SHEN T, Nitta H, Wei L, Parwani AV, et al
    HER2 intratumoral heterogeneity is independently associated with distal metastasis and overall survival in HER2-positive breast carcinomas.
    Breast Cancer Res Treat. 2020;181:519-527.
    PubMed         Abstract available
    
    
35. COOLBRANDT A, T'Jonck A, Blauwens K, Dejaeger E, et al
    Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: patient- and nurse-reported results.
    Breast Cancer Res Treat. 2021 Jan 16. pii: 10.1007/s10549-020-06063.
    PubMed         Abstract available
    
    
36. BIJKERK E, van Kuijk SMJ, Lataster A, van der Hulst RRWJ, et al
    Breast sensibility in bilateral autologous breast reconstruction with unilateral sensory nerve coaptation.
    Breast Cancer Res Treat. 2020;181:599-610.
    PubMed         Abstract available
    
    
37. DOLEN U, Thornton M, Tenenbaum MM, Aripoli A, et al
    A prospective cohort study to analyze the interaction of tumor-to-breast volume in breast conservation therapy versus mastectomy with reconstruction.
    Breast Cancer Res Treat. 2020;181:611-621.
    PubMed         Abstract available
    
    
38. APTECAR L, Fiteni F, Jarlier M, Delaine S, et al
    Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient's dedicated questionnaire: A glaring gap of communication between health professionals and patients.
    Breast Cancer Res Treat. 2021 Jan 15. pii: 10.1007/s10549-020-06062.
    PubMed         Abstract available
    
    
39. AL-MASRI M, Aljalabneh B, Al-Najjar H, Al-Shamaileh T, et al
    Effect of time to breast cancer surgery after neoadjuvant chemotherapy on survival outcomes.
    Breast Cancer Res Treat. 2021 Jan 21. pii: 10.1007/s10549-020-06090.
    PubMed         Abstract available
    
    

    
    Breast J

40. CHOU CP, Pan HB, Yang TL, Chiang CL, et al
    Impact of the COVID-19 pandemic on the volume of mammography examinations in Southern Taiwan.
    Breast J. 2021;27:89-91.
    PubMed        
    
    
41. BARCO I, Garcia-Font M, Garcia-Fernandez A, Fraile M, et al
    Breast cancer patients developing distant metastasis at follow-up: Mortality-related factors.
    Breast J. 2021 Jan 22. doi: 10.1111/tbj.14159.
    PubMed        
    
    
42. ALQATTAN AS, Ghulam WZ, Aldaoud N, Algheryafi L, et al
    Breast fat necrosis secondary to warfarin-induced calciphylaxis, a rare mimicker of breast cancer: A case report and a review of literature.
    Breast J. 2021 Jan 21. doi: 10.1111/tbj.14160.
    PubMed         Abstract available
    
    
43. AL-NAQQASH M, Jasim Al-Serarati W, Farooq Kareem T
    Trastuzumab beyond progression in HER2-positive metastatic breast cancer.
    Breast J. 2021 Jan 20. doi: 10.1111/tbj.14157.
    PubMed        
    
    
44. SROUR MK, Qu Y, Deng N, Carlson K, et al
    Gene expression comparison between primary estrogen receptor-positive and triple-negative breast cancer with paired axillary lymph node metastasis.
    Breast J. 2021 Jan 19. doi: 10.1111/tbj.14119.
    PubMed         Abstract available
    
    
45. DASH I, Pearce BCS, Armstrong S, Saunders C, et al
    Fertility preservation for women undergoing breast cancer treatment: A postcode lottery?
    Breast J. 2020;26:2117-2118.
    PubMed        
    
    
46. XU Y, Hu X, Zhou L, Zhao Y, et al
    Effect of sequencing of preoperative systemic therapy on patients with locally advanced breast cancer.
    Breast J. 2020;26:1987-1994.
    PubMed         Abstract available
    
    
47. AKRAMI M, Mojarad M, Ghoddusi Johari M, Zangouri V, et al
    Do tumor size and biologic features interact with each other?! Which one is more important to affect breast cancer prognosis? Report of a breast cancer registry.
    Breast J. 2020;26:2292-2294.
    PubMed        
    
    
48. DAG A, Edizsoy A
    Challenges in management of idiopathic granulomatous mastitis during the pandemic of COVID-19.
    Breast J. 2021;27:87-88.
    PubMed        
    
    
49. FRANCESCHINI G, Sanchez AM, Scardina L, Terribile D, et al
    Mastectomy with immediate breast reconstruction during "phase 1" COVID-19 emergency: An Italian experience.
    Breast J. 2021;27:80-81.
    PubMed        
    
    

    
    Cancer

50. 
    The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors.
    Cancer. 2020;126:2566-2570.
    PubMed         Abstract available
    
    
51. YUAN Y, Pan K, Mortimer J, Chlebowski RT, et al
    Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
    Cancer. 2021 Jan 21. doi: 10.1002/cncr.33407.
    PubMed         Abstract available
    
    
52. PRINTZ C
    TAILORx study finds early, abrupt cognitive decline among patients with breast cancer.
    Cancer. 2020;126:4083.
    PubMed        
    
    

    
    Cancer Epidemiol Biomarkers Prev

53. MASKARINEC G, Ciba M, Ju D, Shepherd JA, et al
    Association of Imaging-Based Body Fat Distribution and Mammographic Density in the Multiethnic Cohort Adiposity Phenotype Study.
    Cancer Epidemiol Biomarkers Prev. 2020;29:352-358.
    PubMed         Abstract available
    
    
54. OH H, Rice MS, Warner ET, Bertrand KA, et al
    Early-Life and Adult Anthropometrics in Relation to Mammographic Image Intensity Variation in the Nurses' Health Studies.
    Cancer Epidemiol Biomarkers Prev. 2020;29:343-351.
    PubMed         Abstract available
    
    

    
    Cancer Lett

55. LI X, Chen M, Lu W, Tang J, et al
    Targeting FAPalpha-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis.
    Cancer Lett. 2021 Jan 19. pii: S0304-3835(21)00029.
    PubMed         Abstract available
    
    

    
    Cancer Res

56. DI MODICA M, Gargari G, Regondi V, Bonizzi A, et al
    Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer.
    Cancer Res. 2021 Jan 22. pii: 0008-5472.CAN-20-1659.
    PubMed         Abstract available
    
    

    
    Carcinogenesis

57. LIU Y, Zhang A, Bao PP, Lin L, et al
    MicroRNA-374b inhibits breast cancer progression through regulating CCND1 and TGFA genes.
    Carcinogenesis. 2021 Jan 22. pii: 6106539. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

58. HUANG X, Mai J, Huang Y, He L, et al
    Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CT.
    Clin Breast Cancer. 2020 Dec 17. pii: S1526-8209(20)30332.
    PubMed         Abstract available
    
    
59. BALASUBRAMANIAN I, Harding T, Boland MR, Ryan EJ, et al
    The Impact of Postoperative Wound Complications on Oncological Outcomes Following Immediate Breast Reconstruction for Breast Cancer: A Meta-analysis.
    Clin Breast Cancer. 2020 Dec 17. pii: S1526-8209(20)30333.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

60. ALTOE M, Kalinsky K, Marone A, Kim HK, et al
    Changes in diffuse-optical-tomography images during early stages of neoadjuvant chemotherapy correlate with tumor response in different breast cancer subtypes.
    Clin Cancer Res. 2021 Jan 15. pii: 1078-0432.CCR-20-1108.
    PubMed         Abstract available
    
    

    
    Eur Radiol

61. YANG X, Dong M, Li S, Chai R, et al
    Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions.
    Eur Radiol. 2020;30:4795-4805.
    PubMed         Abstract available
    
    
62. YANG Q, Li H, Chen BH, He GZ, et al
    Ultrasound-guided percutaneous microwave ablation for 755 benign breast lesions: a prospective multicenter study.
    Eur Radiol. 2020;30:5029-5038.
    PubMed         Abstract available
    
    

    
    Int J Cancer

63. BYRD DA, Vogtmann E, Wu Z, Han Y, et al
    Associations of fecal microbial profiles with breast cancer and non-malignant breast disease in the Ghana Breast Health Study.
    Int J Cancer. 2021 Jan 18. doi: 10.1002/ijc.33473.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

64. RAHIMI A, Morgan HE, Kim DW, Zhang Y, et al
    Cosmetic outcomes of a phase I dose escalation study of 5-fraction stereotactic partial breast irradiation for early stage breast cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jan 18. pii: S0360-3016(21)00067.
    PubMed         Abstract available
    
    

    
    J Biol Chem

65. OJALA VK, Knittle AM, Kirjalainen P, Merilahti JAM, et al
    The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration.
    J Biol Chem. 2020;295:11559-11571.
    PubMed         Abstract available
    
    
66. HEGDE M, Guruprasad KP, Ramachandra L, Satyamoorthy K, et al
    Interleukin-6-mediated epigenetic control of the VEGFR2 gene induces disorganized angiogenesis in human breast tumors.
    J Biol Chem. 2020;295:12086-12098.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

67. MANDELBLATT JS, Zhou X, Small BJ, Ahn J, et al
    Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living with Cancer Study.
    J Natl Cancer Inst. 2021 Jan 23. pii: 6117333. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

68. XU B, Fan Y
    CDK4/6 inhibition in early-stage breast cancer: how far is it from becoming standard of care?
    Lancet Oncol. 2021 Jan 15. pii: S1470-2045(20)30757.
    PubMed        
    
    
69. MAYER EL, Dueck AC, Martin M, Rubovszky G, et al
    Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.
    Lancet Oncol. 2021 Jan 15. pii: S1470-2045(20)30642.
    PubMed         Abstract available
    
    

    
    Mod Pathol

70. ALHAMAR M, Alkamachi B, Mehrotra H, Sanchez J, et al
    Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents.
    Mod Pathol. 2021 Jan 21. pii: 10.1038/s41379-020-00728.
    PubMed         Abstract available
    
    

    
    N Engl J Med

71. DORLING L, Carvalho S, Allen J, Gonzalez-Neira A, et al
    Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMoa1913948.
    PubMed         Abstract available
    
    
72. NAROD SA
    Which Genes for Hereditary Breast Cancer?
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMe2035083.
    PubMed        
    
    
73. HU C, Hart SN, Gnanaolivu R, Huang H, et al
    A Population-Based Study of Genes Previously Implicated in Breast Cancer.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMoa2005936.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

74. WALSH T, Gulsuner S, Lee MK, Troester MA, et al
    Inherited predisposition to breast cancer in the Carolina Breast Cancer Study.
    NPJ Breast Cancer. 2021;7:6.
    PubMed         Abstract available
    
    
75. MCANDREW NP, Bottalico L, Mesaros C, Blair IA, et al
    Effects of systemic inflammation on relapse in early breast cancer.
    NPJ Breast Cancer. 2021;7:7.
    PubMed         Abstract available
    
    

    
    Oncogene

76. ZHANG H, Wong CCL, Wei H, Gilkes DM, et al
    Correction: HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01618.
    PubMed        
    
    
77. ABRIL YLN, Fernandez IR, Hong JY, Chiang YL, et al
    Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer.
    Oncogene. 2021 Jan 21. pii: 10.1038/s41388-020-01637.
    PubMed         Abstract available
    
    
78. ZHU P, He F, Hou Y, Tu G, et al
    A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability.
    Oncogene. 2021 Jan 19. pii: 10.1038/s41388-020-01638.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

79. GORDIN M, Philip H, Zilberberg A, Gidoni M, et al
    Breast cancer is marked by specific, Public T-cell receptor CDR3 regions shared by mice and humans.
    PLoS Comput Biol. 2021;17:e1008486.
    PubMed         Abstract available
    
    

    
    PLoS One

80. BHANDARI D, Shibanuma A, Kiriya J, Hirachan S, et al
    Factors associated with breast cancer screening intention in Kathmandu Valley, Nepal.
    PLoS One. 2021;16:e0245856.
    PubMed         Abstract available
    
    
81. SAFI N, Saunders C, Hayen A, Anazodo A, et al
    Gestational breast cancer in New South Wales: A population-based linkage study of incidence, management, and outcomes.
    PLoS One. 2021;16:e0245493.
    PubMed         Abstract available
    
    
82. ELLINGJORD-DALE M, Papadimitriou N, Katsoulis M, Yee C, et al
    Coffee consumption and risk of breast cancer: A Mendelian randomization study.
    PLoS One. 2021;16:e0236904.
    PubMed         Abstract available
    
    
83. DE LOS CAMPOS G, Pook T, Gonzalez-Reymundez A, Simianer H, et al
    ANOVA-HD: Analysis of variance when both input and output layers are high-dimensional.
    PLoS One. 2020;15:e0243251.
    PubMed         Abstract available
    
    
84. ALLMAN R, Spaeth E, Lai J, Gross SJ, et al
    A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score.
    PLoS One. 2021;16:e0245375.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

85. DAMAGHI M, West J, Robertson-Tessi M, Xu L, et al
    The harsh microenvironment in early breast cancer selects for a Warburg phenotype.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: